ETAMSILAT ZENTIVA 250mg 250mg / 2ml injectible solution medication leaflet

B02BX01 etamsylate • Blood and blood forming organs | Vitamin k and other hemostatics | Other systemic hemostatics

Etamsylate is a medication used to stop or prevent bleeding, recommended in various situations such as surgical interventions, nosebleeds, heavy menstruation, or other conditions involving vascular fragility. It works by increasing capillary resistance and stimulating platelet formation, thus helping to stop bleeding.

Etamsylate is administered orally as tablets or by injection, depending on the severity of the situation and the doctor's recommendation. The dose and duration of treatment are determined individually, according to each patient's needs.

Side effects may include mild digestive disorders, allergic reactions, headaches, or, rarely, low blood pressure. In general, etamsylate is well tolerated, but it is important that the treatment is followed under medical supervision.

Etamsylate is an effective solution for controlling bleeding, being useful both in emergencies and in preventing recurrences in patients at high risk of hemorrhage.

General data about ETAMSILAT ZENTIVA 250mg 250mg / 2ml

Substance: etamsylate

Date of last drug list: 01-06-2025

Commercial code: W57392002

Concentration: 250mg / 2ml

Pharmaceutical form: injectible solution

Packing volume: 2 ml

Product type: generic

Price: 58.09 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: ZENTIVA S.A. - ROMANIA

Holder: ZENTIVA S.A. - ROMANIA

Number: 12401/2019/01

Shelf life: 3 years

Pharmaceutical forms available for etamsylate

Concentrations available for etamsylate

125mg/ml, 250mg, 250mg/2ml

Compensation lists for ETAMSILAT ZENTIVA 250mg 250mg / 2ml ZENTIVA

C3 - Sublist C - section C3 (children, pregnant women and children) with 100% discount from the reference price

Price

Copayment

Patient

58.09 RON

58.09 RON

0.00 RON